Correlation Between Provectus Biopharmaceutica and Aerovate Therapeutics

Can any of the company-specific risk be diversified away by investing in both Provectus Biopharmaceutica and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Provectus Biopharmaceutica and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Provectus Biopharmaceuticals and Aerovate Therapeutics, you can compare the effects of market volatilities on Provectus Biopharmaceutica and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Provectus Biopharmaceutica with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Provectus Biopharmaceutica and Aerovate Therapeutics.

Diversification Opportunities for Provectus Biopharmaceutica and Aerovate Therapeutics

-0.67

Correlation Coefficient

Provectus Biopharmaceutica  Aerovate Therapeutics

Excellent diversification

The 3 months correlation between Provectus and Aerovate is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Provectus Biopharmaceuticals and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Provectus Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Provectus Biopharmaceuticals are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Provectus Biopharmaceutica i.e., Provectus Biopharmaceutica and Aerovate Therapeutics go up and down completely randomly.

Pair Corralation between Provectus Biopharmaceutica and Aerovate Therapeutics

If you would invest  11.00  in Provectus Biopharmaceuticals on September 23, 2024 and sell it today you would earn a total of  0.00  from holding Provectus Biopharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	4.76%
Values	Daily Returns

Provectus Biopharmaceuticals  vs.  Aerovate Therapeutics

Provectus Biopharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Provectus Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Provectus Biopharmaceutica is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Aerovate Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Provectus Biopharmaceutica and Aerovate Therapeutics

The main advantage of trading using opposite Provectus Biopharmaceutica and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Provectus Biopharmaceutica position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.

The idea behind Provectus Biopharmaceuticals and Aerovate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.